Cerus (CERS) Misses Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Cerus Corporation Announces Record Fourth Quarter and Full Year 2018 Results
February 26, 2019 4:02 PM ESTCONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq: CERS) today announced complete financial results for the fourth quarter and year ended December 31, 2018.
Recent developments and highlights include:
Record fourth quarter product revenue of $16.5 million. Provided 2019 annual product revenue guidance of $70 million to $73 million, representing a 15% to 20% increase over 2018 reported product revenue. Filed CE Mark registration for the Companys INTERCEPT Blood System for red blood cells (RBCs). Initiated enrollment in ReCePI, Cerus U.S.... More